Wessels H - Search Results

1

Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia.

Gökbuget N, Dombret H, Bonifacio M, Reichle A, Graux C, Faul C, Diedrich H, Topp MS, Brüggemann M, Horst HA, Havelange V, Stieglmaier J, Wessels H, Haddad V, Benjamin JE, Zugmaier G, Nagorsen D, Bargou RC. Gökbuget N, et al. Among authors: wessels h. Blood. 2018 Apr 5;131(14):1522-1531. doi: 10.1182/blood-2017-08-798322. Epub 2018 Jan 22. Blood. 2018. PMID: 29358182 Free PMC article. Clinical Trial.

2

Cell cycle kinetics in malignant lymphoma studied with in vivo iododeoxyuridine administration, nuclear Ki-67 staining, and flow cytometry.

Brons PP, Raemaekers JM, Bogman MJ, van Erp PE, Boezeman JB, Pennings AH, Wessels HM, Haanen C. Brons PP, et al. Among authors: wessels hm. Blood. 1992 Nov 1;80(9):2336-43. Blood. 1992. PMID: 1421404 Free article.

3

Proliferation patterns in acute myeloid leukemia: leukemic clonogenic growth and in vivo cell cycle kinetics.

Brons PP, Haanen C, Boezeman JB, Muus P, Holdrinet RS, Pennings AH, Wessels HM, de Witte T. Brons PP, et al. Among authors: wessels hm. Ann Hematol. 1993 May;66(5):225-33. doi: 10.1007/BF01738470. Ann Hematol. 1993. PMID: 8507717

4

Triggering noncycling hematopoietic progenitors and leukemic blasts to proliferate increases anthracycline retention and toxicity by downregulating multidrug resistance.

Smeets ME, Raymakers RA, Vierwinden G, Pennings AH, Wessels H, de Witte T. Smeets ME, et al. Among authors: wessels h. Blood. 1999 Oct 1;94(7):2414-23. Blood. 1999. PMID: 10498614 Free article.

5

S-phase DNA content and aneuploidy of immunophenotypic defined subpopulations in acute myeloid leukemia determined by multi-parameter flow cytometry.

Brons P, Pennings A, Haanen C, Wessels H, Boezeman J. Brons P, et al. Among authors: wessels h. Leuk Res. 1991;15(9):827-35. doi: 10.1016/0145-2126(91)90467-8. Leuk Res. 1991. PMID: 1921460

6

Cellular and plasma adriamycin concentrations in long-term infusion therapy of leukemia patients.

Speth PA, Linssen PC, Boezeman JB, Wessels HM, Haanen C. Speth PA, et al. Among authors: wessels hm. Cancer Chemother Pharmacol. 1987;20(4):305-10. doi: 10.1007/BF00262581. Cancer Chemother Pharmacol. 1987. PMID: 3480081

7

In vivo cellular adriamycin concentrations related to growth inhibition of normal and leukemic human bone marrow cells.

Speth PA, Raijmakers RA, Boezeman JB, Linssen PC, de Witte TJ, Wessels HM, Haanen C. Speth PA, et al. Among authors: wessels hm. Eur J Cancer Clin Oncol. 1988 Apr;24(4):667-74. doi: 10.1016/0277-5379(88)90297-0. Eur J Cancer Clin Oncol. 1988. PMID: 3383969

8

Leukemic cell and plasma daunomycin concentrations after bolus injection and 72 h infusion.

Speth PA, Linssen PC, Boezeman JB, Wessels HM, Haanen C. Speth PA, et al. Among authors: wessels hm. Cancer Chemother Pharmacol. 1987;20(4):311-5. doi: 10.1007/BF00262582. Cancer Chemother Pharmacol. 1987. PMID: 3690804

9

Plasma and cellular pharmacokinetics of m-AMSA related to in vitro toxicity towards normal and leukemic clonogenic bone marrow cells (CFU-GM, CFU-L).

Linssen P, Brons P, Knops G, Wessels H, de Witte T. Linssen P, et al. Among authors: wessels h. Eur J Haematol. 1993 Mar;50(3):149-54. doi: 10.1111/j.1600-0609.1993.tb00083.x. Eur J Haematol. 1993. PMID: 8472810

10

Simultaneous measurement of DNA content and cell-surface immunofluorescence of human bone marrow cells using a single laser flow cytometer.

Brons PP, Pennings AH, Haanen C, Wessels HM, Boezeman JB. Brons PP, et al. Among authors: wessels hm. Cytometry. 1990;11(7):837-44. doi: 10.1002/cyto.990110710. Cytometry. 1990. PMID: 1703067 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

212 results

Search Page

Filters